|
Mar 4
|
Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance
|
|
Mar 4
|
Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan
|
|
Mar 1
|
Iovance Biotherapeutics Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 28
|
IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty
|
|
Feb 28
|
Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ...
|
|
Feb 27
|
Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 27
|
Iovance Biotherapeutics: Q4 Earnings Snapshot
|
|
Feb 27
|
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
|
|
Feb 24
|
What's in Store for These 5 Biotech Stocks This Earnings Season?
|
|
Feb 20
|
Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know
|
|
Feb 18
|
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
|
|
Feb 17
|
High Growth Tech Stocks In The United States To Watch
|
|
Feb 10
|
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
|
|
Jan 3
|
Exploring 3 High Growth Tech Stocks In The United States
|
|
Jan 3
|
Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
|
|
Jan 2
|
Why Iovance Biotherapeutics Inc. (IOVA) Is Skyrocketing
|
|
Oct 4
|
Is Iovance Biotherapeutics Stock a Buy?
|
|
Oct 3
|
High Growth Tech Stocks to Watch in October 2024
|
|
Sep 26
|
3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
|
|
Aug 27
|
Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
|